Buckman CO is categorized under Commercial Medical Research in Concord, CA and active since 1981.
Buckman CO was established in 1981, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 3391120 by the NAICS.
If you are seeking more information, feel free to contact Pamela Buckman, Owner at the company’s single location by writing to 2280 Diamond Boulevard # 340, Concord, California CA 94520 or by phoning (925) 705-7380. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Buckman CO |
| Contact Person: | Pamela Buckman, Owner |
| Address: | 2280 Diamond Boulevard # 340, Concord, California 94520 |
| Phone Number: | (925) 705-7380 |
| Website Address: | fda-help.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1981 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 3391120 |
| Share This Business: |
Buckman CO was started in 1981 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 3391120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Pamela Buckman, Owner for inquiries that concern Buckman CO by calling the company number (925) 705-7380, as your correspondence is most welcome. Additionally, the physical location of the single location of Buckman CO can be found at the coordinates 37.977731,-122.060977 as well as the street address 2280 Diamond Boulevard # 340 in Concord, California 94520.
For its online presence, you may visit Buckman CO’s website at fda-help.com and engage with its social media outlets through on Twitter and on Facebook.